Product Information
GNP FLUTICASONE PROP 50 MCG SP is a generic product labeled by AmerisourceBergen, priced at $0.6757 per ML under NDC 46122068429. Its NADAC has been published 223 times since Jun 29, 2022.
FDA first approved this application on May 26, 2016.
Strength
50 ug/1
Manufacturer
AmerisourceBergenNDC
46122068429
Classification
Generic
Dosage Form
SPRAY, METERED
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
FLUTICASONE PROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA207957FDA Approved
5/26/2016
On Market Since
1/26/2021
Pharmacological Classes
Price Statistics
The NADAC for GNP FLUTICASONE PROP 50 MCG SP has been published 223 times since Jun 29, 2022, and over the history we have for it it has declined 17.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6757 per ML |
|---|---|
| All-time high | $0.8154 (Jul 13, 2022) |
| All-time low | $0.6661 (Oct 22, 2025) |
| 52-week high | $0.6993 |
| 52-week low | $0.6661 |
| Median price | $0.6994 |
| Average price | $0.7151 |
| Largest weekly change | -7.3% (May 17, 2023) |
| Weeks tracked | 223 |
| Tracking since | Jun 29, 2022 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fluticasone propionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP FLUTICASONE PROP 50 MCG SP?
The current National Average Drug Acquisition Cost (NADAC) for GNP FLUTICASONE PROP 50 MCG SP, manufactured by AmerisourceBergen, is $0.6757 per ML (NDC 46122068429), effective Sep 30, 2026.
How has the price of GNP FLUTICASONE PROP 50 MCG SP changed over time?
Over the history we have for it, the NADAC for GNP FLUTICASONE PROP 50 MCG SP has declined 17.1%. It has been tracked across 223 weekly CMS publications since Jun 29, 2022.
What are the highest and lowest recorded NADAC prices for GNP FLUTICASONE PROP 50 MCG SP?
Since Jun 29, 2022, the NADAC for GNP FLUTICASONE PROP 50 MCG SP has ranged from a low of $0.6661 (Oct 22, 2025) to a high of $0.8154 (Jul 13, 2022), with a median of $0.6994 per ML.
Are there cheaper alternatives to GNP FLUTICASONE PROP 50 MCG SP?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GNP FLUTICASONE PROP 50 MCG SP in a comparable dosage form, but none are currently priced below it.
Who manufactures GNP FLUTICASONE PROP 50 MCG SP?
GNP FLUTICASONE PROP 50 MCG SP (NDC 46122068429) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.